Abstract Neural tube defects (NTD) are likely to result from an interaction of several genes and environmental factors. Because periconceptional folate intake reduces the NTD risk in the fetus, and because mothers of children with NTD showed elevated plasma homocysteine levels, gene polymorphisms of the folate and homocysteine pathway, such as 5,10-methylenetetrahydrofolate reductase (MTHFR) 677CAET, MTHFR 1298AAEC and cystathionine -synthase (CBS) 844ins68, have been implicated in the etiology of NTD. Several studies have demonstrated that these polymorphisms may indeed be associated with NTD in some populations. In order to evaluate the role of these polymorphisms and their interaction in NTD, we genotyped 417 individuals for case-control studies and 129 families for transmission disequilibrium tests. We are the first to present detailed data on MTHFR haploid genotypes in combination with CBS 844ins68. The MTHFR risk genotype 677CT/1298AC, known to be associated with decreased enzyme activity and increased homocysteine, was found significantly more often in patients than in controls (P ϭ 0.02). A CBS insertion allele in addition to MTHFR 677CT/ 1298AC heterozygosity or MTHFR 677TT/1298AA homozygosity did not result in an increased risk for NTD. This is in agreement with the recently reported homocysteine-lowering effect of the CBS 844ins68 allele in carriers of MTHFR variants.
Introduction
Nonsyndromic neural tube defects (NTD) are among the most frequent congenital malformations, with an estimated prevalence at birth of about 1 : 1000 in most populations. NTD are thought to be of multifactorial origin, involving a number of as yet unknown genetic and environmental factors. Randomized trials in different populations have demonstrated that the occurrence and recurrence risk of NTD is reduced by folic acid supplementation taken during the periconceptional period (Berry et al. 1999; Czeizel and Dudás 1992; MRC Vitamin Study Research Group 1991) . The protective effect of folic acid has led to a search for candidate genes involved in its metabolic pathway. The enzymes 5,10-methylenetetrahydrofolate reductase (MTHFR) and cystathionine -synthase (CBS), are promising candidates for folate-sensitive NTD, accounting for about 70% of human NTD. Both enzymes participate in the folate-dependent metabolism of homocysteine, and genetic defects in these enzymes can cause hyperhomocysteinemia, which has been found in mothers of NTD-affected children . Because hyperhomocysteinemia is correctable by folic acid intake (Kang et al. 1988) , it has been speculated that decreasing the plasma homocysteine level might be the mechanism responsible for the NTDpreventive effect of folic acid (Mills et al. 1996; Piedrahita et al. 1999) .
MTHFR catalyzes the reduction of 5,10-methylenetetrahydrofolate (THF) to 5-methyl-THF, which is required as a cosubstrate in the remethylation of homocysteine to methionine. The thermolabile variant of MTHFR due to the common polymorphism 677CAET has reduced enzyme activity van der Put et al. 1995) , resulting in mild hyperhomocysteinemia, especially if the folate status is poor (Jacques et al. 1996) . It has therefore been postulated that 677TT-homozygotes have an increased folate requirement to regulate their homocysteine levels . Initial investigations showed that this polymorphism may be associated with NTD in some populations. A significant increase in the 677TT homozygosity rate in NTD cases compared with controls was independently reported in the Irish and Dutch populations (van der Put et al. 1995; Whitehead et al. 1995) . Subsequent population-based studies have confirmed the association of TT-homozygosity and NTD Shields et al. 1999) , although other studies of similar design have failed to do so (Morrison et al. 1998; Speer et al. 1997; Stegmann et al. 1999) . Recently, it was suggested that a second MTHFR polymorphism, 1298AAEC, confers an additional NTD risk. Combined heterozygosity of MTHFR 677CT/1298AC tended to be more frequent in Dutch NTD patients than in controls, although without reaching significance (odds ratio [OR] , 2.04; 95% confidence interval [CI], 0.89-4.70; van der Put et al. 1998) . Individuals with this genotype combination showed reduced MTHFR activity, elevated plasma homocysteine, and decreased plasma folate, although these features were less pronounced than in 677TT homozygotes (van der Put et al. 1998) . Data for other populations failed to confirm an association between NTD and MTHFR 677CT/1298AC (Barber et al. 2000; Stegmann et al. 1999; Trembath et al. 1999) .
Because failure of human neural tube closure is likely to result from an interaction of several genes, the cystathionine -synthase (CBS) polymorphism 844ins68 has been investigated as an additional risk factor in NTD. All studies so far have found that CBS 844ins68 alone was not associated with NTD (Akar et al. 2000; de Franchis et al. 1997; Morrison et al. 1998; Ramsbottom et al. 1997; Speer et al. 1999) . Regarding a possible gene-gene interaction between MTHFR and CBS, the results were conflicting. Three casecontrol studies were unable to reveal a significant association of MTHFR 677TT homozygosity in conjunction with CBS 844ins68 heterozygosity and NTD (Morrison et al. 1998; Ramsbottom et al. 1997; Speer et al. 1999) . However, in the Italian sample, NTD patients homozygous for 677TT significantly more often carried an additional CBS 844ins68 allele than 677TT controls (de Franchis et al. 1997 ). In the American study, the difference in MTHFR-CBS combination data between patients and controls became significant after pooling with Irish controls (Speer et al. 1999) . It seems that the CBS 844ins68 allele acts as an additional risk factor for NTD, at least in some populations. In order to evaluate a synergistic involvement of these folate and homocysteine pathway genotypes in German NTD cases, we investigated the distributions of the two MTHFR genotypes and CBS 844ins68 separately, and in combination with each other, in patients, their parents, and controls. According to our results there was no statistically significant association for any of the polymorphisms when evaluated separately. However, our data provide evidence for an interaction between the MTHFR polymorphisms, because the frequency of the compound MTHFR genotype 677CT/1298AC is significantly increased in NTD cases. The coexistence of a CBS insertion allele with MTHFR 677TT/1298AA or CT/AC did not result in an increased risk for NTD.
Methods

Probands and controls
The study group consisted of 184 German patients (169 nonfamilial, 15 familial) with a non-syndromic neural tube defect (9 anencephalics, 3 encephaloceles, 172 spina bifida aperta). Spina bifida aperta (SBA) families were recruited from an ambulatory Spina bifida clinic, and fetuses were obtained from the fetal pathology unit of our medical center. The control population consisted of 233 unrelated healthy German volunteers (males and females).
For the case-control association study, all NTD patients and control subjects were genotyped for MTHFR 677C/T, MTHFR 1298A/C, and CBS 844ins68. For the family-based association study, 98 trios (mother, father, SBA child) and 31 parent-offspring pairs were genotyped to investigate transmission disequilibrium of the MTHFR and CBS alleles.
The study was approved by the Ethics Committee of the University of Marburg, and informed consent was obtained from patients, parents, and control individuals.
DNA analysis
Genotyping for MTHFR 677C/T and 1298A/C was done as described by Stegmann et al. (1999) , including an amplification refractory mutation system (ARMS) test to determine the haplotype of all individuals heterozygous at both MTHFR sites (677CT-1298AC). Genotyping for CBS 844ins68 was performed using primers previously reported by Ramsbottom et al. (1997) . The 68-bp insertion in exon 10 of CBS was reported to cosegregate with the frequent mutation 833TAEC (I278T) in cis (Kozich and Kraus 1992; Kraus et al. 1998; Tsai et al. 1996) . We verified the 833CAET nucleotide exchange on all insertion alleles by digesting the polymerase chain reaction (PCR) product with the restriction enzyme BsrI, as described by Kozich and Kraus (1992) .
Statistics
The distributions of genotypes and genotype combinations in cases and controls were compared using Fisher's onesided exact test at a 5% significance level. The transmission disequilibrium test (TDT) was applied to analyze transmission disequilibrium in trios and parent-offspring pairs (Sun et al. 1999) .
Results
MTHFR genotypes 677C/T-1298A/C in combination with CBS genotype 844ins68 for cases and controls (n ϭ 184 ϩ 233 ϭ 417) are given in Table 1 .
Observed frequencies of the 677TT genotype (677T allele) were 28/184 (15.2%) (0.38) in cases and 27/233 (11.6%) (0.32) in controls, and observed frequencies of the 1298CC genotype (1298C allele) were 12/184 (6.5%) (0.30) in cases and 25/233 (10.7%) (0.29) in controls. Comparison of patients with controls revealed no significant difference in 677TT (P ϭ 0.16) and 1298CC (P ϭ 0.08) homozygosity. Analyses of the 98 family trios and the 31 parent-offspring pairs failed to detect transmission disequilibrium for the 677T-allele (transmitted : nontransmitted, 57 : 57; P ϭ 1.00) and the 1298C-allele (52 : 53; P ϭ 1.00).
The MTHFR genotype combinations 677CT/1298CC, TT/AC, and TT/CC were not observed (Stegmann et al. 1999; van der Put et al. 1998 ). All individuals homozygous for one MTHFR mutation were homozygous wild-type for the other (677TT/1298AA and CC/CC). Haplotyping proved that combined heterozygotes always carried the two mutations in trans (677CT/1298AC). The frequency of this compound heterozygous genotype CT/AC was significantly increased in patients (45/184) compared with controls (38/ 233; P ϭ 0.02).
We found CBS 844ins68 heterozygosity (homozygosity) in 21/184; 11.4% (1/184; 0.5%) of cases and in 39/233; 16.7% (3/233; 1.3%) of controls. In all CBS 844ins68 alleles, the 833TAEC mutation was found in cis. There was no significant difference in CBS genotype distribution (insertion [ins]/ins ϩ wild-type [wt]/ins) comparing patients (22/184) and controls (42/233, P ϭ 0.051). Analysis of the trios and parent-offspring pairs revealed no transmission disequilibrium (transmitted: nontransmitted, 14 : 16; P ϭ 1.00). The overall insertion allele frequency in the 417 individuals was 0.082 (68/834).
All CBS 844ins68 homozygotes were MTHFR 677CC. The lack of a 677T allele in combination with homozygosity for CBS 844ins68 is probably due to the low population frequency of the insertion allele and not to a true linkage disequilibrium. To evaluate a CBS-MTHFR gene-gene interaction, we tested whether patients with the MTHFR genotypes 677TT/1298AA or CT/AC more frequently carried additional CBS 844ins68 alleles than controls ( Table 2) . The coexistence of a CBS insertion allele with MTHFR TT/ AA or CT/AC genotype did not result in an increased risk for NTD (P ϭ 1.00).
Discussion
The mechanism by which low folate and elevated homocysteine disrupt neural tube development in humans is still unexplained. For the targeted Cart1 knockout mouse and the spontaneously arisen Splotch phenotype, folic acid treatment has been reported to decrease the risk of NTD (Fleming and Copp 1998; Zhao et al. 1996) . However, folate deficiency alone did not lead to NTD in mice (Heid et al. 1992) , consistent with the well supported hypothesis that the preventive effect consists not simply of compensating a nutritional deficiency (Mills et al. 1996) . Possibly, folate acts by lowering homocysteine. High doses of homocysteine can induce NTD in chicken embryos, a teratogenic effect that is preventable by folic acid (Rosenquist et al. 1996) . The results of these experiments in animal models have encouraged the examination of functional relevant gene polymorphisms of the folate and homocysteine pathway in relation to human NTD.
Population-based association studies of single polymorphisms have produced conflicting data, probably due to phenotypic heterogeneity, ethnic differences in genotype distributions, and the polygenic etiology in NTD. Therefore, in the present study, we took into consideration the different phenotypes and used ethnically homogeneous case-control groups. With regard to the polygenic etiology, we especially focused on the impact of possible interactions between folate and homocysteine pathway genotypes. including: 9 anencephalic cases: 1 ϫ CC/AA -wt/wt, 1 ϫ CC/ACwt/ins, 2 ϫ CT/AA -wt/wt, 3 ϫ CT/AC -wt/wt, 2 ϫ TT/AAwt/wt and 3 encephalic cases: 2 ϫ CC/AA -wt/wt, 1 ϫ CT/AAwt/wt Three polymorphisms were investigated: MTHFR 677CAET, MTHFR 1298AAEC, and CBS 844ins68. Comparing NTD patients with controls, we found no significant difference in allele and genotype frequencies for any polymorphism regarded separately (Table 1) . Similarily, our family-based analyses detected no linkage disequilibrium. The lack of association between the single MTHFR genotypes and German NTD cases is in agreement with our previous results and with data from other studies (Boduroglu et al. 1999; Mornet et al. 1997; Morrison et al. 1998; Shaw et al. 1998) . Our MTHFR genotype and allele frequencies showed intermediate values, comparable to frequencies in North European-derived populations (Botto and Yang 2000; Fletcher and Kessling 1998) .
So far, only a few studies have looked for an association between the CBS insertion allele and NTD in Caucasians (Akar et al. 2000; de Franchis et al. 1997; Morrison et al. 1998; Ramsbottom et al. 1997; Speer et al. 1999) . As in our present study, none of them found an association. We found a rate of CBS 844ins68 homozygosity of 0.96% (4/417 individuals), corresponding well to the expected proportion, given the insertion allele frequency of 0.08. Our low homozygosity rate is in agreement with population data demonstrating that CBS 844ins68 homozygosity is rare in black Africans (4%) and nearly absent in Europeans and Asians (less than 1%) (Franco et al. 1998; Pepe et al. 1999) .
In a combined analysis, we detected a significantly increased frequency of the MTHFR haploid genotype 677CT/ 1298AC among patients compared with controls (P ϭ 0.02). Therefore, in contrast to our previous study, our data now provide evidence for an interaction between both MTHFR polymorphisms. In our 1999 study, we presented the more conservative two-sided P values, whereas we now give onesided P values. However, for the present study, even the two-sided test resulted in a P value of less than 0.05. Exclusion of the cranial phenotypes (n ϭ 12) from all computations did not change statistical significance.
A comparison with findings in the literature is difficult, because our data consist of experimentally established haploid genotypes, whereas in other studies the 677CT/1298AC genotypes are mostly inferred from the absent combinations 677CT/1298CC, 677TT/1298AC, and 677TT/1298CC. Although the risk genotype 677CT/1298AC was proposed by van der Put et al. (1998) , the Dutch and American data so far have failed to show unambigious significance (Barber et al. 2000; Trembath et al. 1999; van der Put et al. 1998 ). Our study is the first to present reliable and statistically significant data for an association of MTHFR risk genotypes with NTD. The risk genotypes 677TT/1298AA and CT/AC may be of biological significance, because they have been shown to be associated with decreased MTHFR enzyme activity and elevated plasma homocysteine (Weisberg et al. 1998) .
Another important enzyme in the control of plasma homocysteine levels is CBS, which catalyzes the first step in the catabolic pathway. In order to explore a possible MTHFR-CBS gene-gene interaction as an NTD risk factor, we tested whether the MTHFR risk genotypes 677TT/ 1298AA and CT/AC were associated with an additional CBS 844ins68 allele in NTD patients (Table 2 ). In contrast to the Italian study (de Franchis et al. 1997 ), but in agreement with other studies (Morrison et al. 1998; Ramsbottom et al. 1997; Speer et al. 1999 ), we could not detect an additional risk conferred by the CBS insertion allele (P ϭ 1.00). After pooling their own American group with published Irish controls, Speer et al. (1999) found a significant effect. However, pooling groups of different ethnic origin appears problematic in association studies sensitive to stratification effects.
The lack of association of CBS 844ins68 with NTD should be regarded in context with recent findings that the insertion allele is not associated with increased homocysteine plasma levels. Instead, hyperhomocysteinemia due to thermolabile MTHFR was absent in those 677TT-homozygote individuals who carried an additional CBS 844ins68 allele (de Stefano et al. 1998; Tsai et al. 1999) . In contrast to initial concepts (Sebastio et al. 1995) , the insertion creates an alternative splice site eliminating both sequence variants, 833TAEC and 844ins68, resulting in normal mRNA and enzyme (Tsai et al. 1996) . At present, it is not clear how the observed homocysteine-lowering effect is produced in these individuals. In any case, CBS 844ins68 obviously is not responsible for elevated homocysteine levels. Therefore, CBS 844ins68 seems not to be a good candidate for NTD in connection with hyperhomocysteinemia.
